UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Monalizumab: inhibiting the novel immune checkpoint NKG2A

Journal for immunotherapy of cancer, 2019-10, Vol.7 (1), p.263-8, Article 263

2019

Volltextzugriff (PDF)

The NKG2A-HLA-E Axis as a Novel Checkpoint in the Tumor Microenvironment

Clinical cancer research, 2020-11, Vol.26 (21), p.5549-5556

2020

Volltextzugriff (PDF)

NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division

International journal of cancer, 2022-02, Vol.150 (4), p.688-704

2022

Volltextzugriff (PDF)

The urgent need to recover MHC class I in cancers for effective immunotherapy

Current opinion in immunology, 2016-04, Vol.39, p.44-51

2016

Volltextzugriff (PDF)

Vaccines for established cancer: overcoming the challenges posed by immune evasion

Nature reviews. Cancer, 2016-04, Vol.16 (4), p.219-233

2016

Volltextzugriff (PDF)

Interleukin‐6‐mediated resistance to immunotherapy is linked to impaired myeloid cell function

International journal of cancer, 2021-01, Vol.148 (1), p.211-225

2021

Volltextzugriff (PDF)

Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes

PloS one, 2016-10, Vol.11 (10), p.e0164292-e0164292

2016

Volltextzugriff (PDF)

Thermal‐exchange HLA‐E multimers reveal specificity in HLA‐E and NKG2A/CD94 complex interactions

Immunology, 2023-03, Vol.168 (3), p.526-537

2023

Volltextzugriff (PDF)

Immunotherapeutic Potential of TGF-β Inhibition and Oncolytic Viruses

Trends in immunology, 2020-05, Vol.41 (5), p.406-420

2020

Volltextzugriff (PDF)

Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T‐cell activation

European journal of immunology, 2013-10, Vol.43 (10), p.2554-2565

2013

Volltextzugriff (PDF)

Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights

International journal of molecular sciences, 2021-08, Vol.22 (17), p.9401

2021

Volltextzugriff (PDF)

Cross-presentation of a TAP-independent signal peptide induces CD8 T immunity to escaped cancers but necessitates anchor replacement

Cancer Immunology, Immunotherapy, 2022-02, Vol.71 (2), p.289-300

2022

Volltextzugriff (PDF)

Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model

Gut, 2022-11, Vol.71 (11), p.2266-2283

2022

Volltextzugriff (PDF)

Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity

Nature communications, 2019-08, Vol.10 (1), p.3773-13, Article 3773

2019

Volltextzugriff (PDF)

Future Challenges in Cancer Resistance to Immunotherapy

Cancers, 2020-04, Vol.12 (4), p.935

2020

Volltextzugriff (PDF)

M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells

The Journal of immunology (1950), 2011-08, Vol.187 (3), p.1157-1165

2011

Volltextzugriff (PDF)

The Immunogenicity of a Proline-Substituted Altered Peptide Ligand toward the Cancer-Associated TEIPP Neoepitope Trh4 Is Unrelated to Complex Stability

The Journal of immunology (1950), 2018-04, Vol.200 (8), p.2860-2868

2018

Volltextzugriff (PDF)

Strategies to counteract MHC-I defects in tumors

Current opinion in immunology, 2011-04, Vol.23 (2), p.293-298

2011

Volltextzugriff (PDF)

Immunogenicity of rat-neu+ mouse mammary tumours determines the T cell-dependent therapeutic efficacy of anti-neu monoclonal antibody treatment

Scientific reports, 2020-03, Vol.10 (1), p.3933-3933, Article 3933

2020

Volltextzugriff (PDF)

PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy

Oncoimmunology, 2017-04, Vol.6 (4), p.e1294299-e1294299

2017

Volltextzugriff (PDF)

HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+T lymphocytes

Proceedings of the National Academy of Sciences - PNAS, 2011-06, Vol.108 (26), p.10656-10661

2011

Volltextzugriff (PDF)

Alternative Antigen Processing for MHC Class I: Multiple Roads Lead to Rome

Frontiers in immunology, 2015-06, Vol.6, p.298-298

2015

Volltextzugriff (PDF)

A herpesvirus encoded Qa-1 mimic inhibits natural killer cell cytotoxicity through CD94/NKG2A receptor engagement

eLife, 2018-12, Vol.7

2018

Volltextzugriff (PDF)

T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors

Nature communications, 2024-01, Vol.15 (1), p.48-48, Article 48

2024

Volltextzugriff (PDF)

1 – 25 von 160

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(149)

Publikationsform

Sprache

Englisch
(160)

Erscheinungsjahr

n.n

Thema

Science & Technology
(118)
Life Sciences & Biomedicine
(103)
Animals
(71)
Immunology
(68)
Humans
(63)
Mice
(63)
Oncology
(56)
Immunotherapy
(47)
Tumors
(40)
Lymphocytes
(38)
Cancer
(37)
Mice, Inbred C57bl
(31)
Peptides
(30)
Histocompatibility Antigens Class I - Immunology
(26)
Lymphocytes T
(25)
Antigen Presentation
(24)
Cd8-Positive T-Lymphocytes - Immunology
(23)
Cell Line, Tumor
(22)
Female
(22)
Antigens
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Monalizumab: inhibiting the novel immune checkpoint NKG2A

The NKG2A-HLA-E Axis as a Novel Checkpoint in the Tumor Microenvironment

NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division

The urgent need to recover MHC class I in cancers for effective immunotherapy

Vaccines for established cancer: overcoming the challenges posed by immune evasion

Interleukin‐6‐mediated resistance to immunotherapy is linked to impaired myeloid cell function

Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes

Thermal‐exchange HLA‐E multimers reveal specificity in HLA‐E and NKG2A/CD94 complex interactions

Immunotherapeutic Potential of TGF-β Inhibition and Oncolytic Viruses

Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T‐cell activation

Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights

Cross-presentation of a TAP-independent signal peptide induces CD8 T immunity to escaped cancers but necessitates anchor replacement

Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model

Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity

Future Challenges in Cancer Resistance to Immunotherapy

M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells

The Immunogenicity of a Proline-Substituted Altered Peptide Ligand toward the Cancer-Associated TEIPP Neoepitope Trh4 Is Unrelated to Complex Stability

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

Strategies to counteract MHC-I defects in tumors

Immunogenicity of rat-neu+ mouse mammary tumours determines the T cell-dependent therapeutic efficacy of anti-neu monoclonal antibody treatment

PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy

HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+T lymphocytes

Alternative Antigen Processing for MHC Class I: Multiple Roads Lead to Rome

A herpesvirus encoded Qa-1 mimic inhibits natural killer cell cytotoxicity through CD94/NKG2A receptor engagement

T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors

Suchergebnisse filtern